X-1309528-G-A
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000355432.8(CSF2RA):c.1073G>A(p.Arg358Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0121 in 1,613,780 control chromosomes in the GnomAD database, including 195 homozygotes. There are 10,195 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R358L) has been classified as Benign.
Frequency
Consequence
ENST00000355432.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF2RA | NM_172245.4 | c.*49G>A | 3_prime_UTR_variant | 13/13 | ENST00000381529.9 | NP_758448.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF2RA | ENST00000381529.9 | c.*49G>A | 3_prime_UTR_variant | 13/13 | 1 | NM_172245.4 | ENSP00000370940 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00916 AC: 1393AN: 152074Hom.: 9 Cov.: 33 AF XY: 0.00946 AC XY: 703AN XY: 74292
GnomAD3 exomes AF: 0.0116 AC: 2901AN: 251160Hom.: 36 AF XY: 0.0131 AC XY: 1778AN XY: 135722
GnomAD4 exome AF: 0.0124 AC: 18193AN: 1461588Hom.: 186 Cov.: 33 AF XY: 0.0131 AC XY: 9492AN XY: 727078
GnomAD4 genome AF: 0.00915 AC: 1392AN: 152192Hom.: 9 Cov.: 33 AF XY: 0.00945 AC XY: 703AN XY: 74420
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 01, 2022 | p.Arg358Gln in exon 11 of CSF2RA: This variant is not expected to have clinical significance because it has been identified in 3% (927/30780) of South Asian chromosomes, including 17 homozygotes and 1.2% (1538/128868) of European chromosomes, including 13 homozygotes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1; BP4. - |
CSF2RA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 10, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at